ICON plc (ICLR)
173.48
+1.25
(+0.73%)
USD |
NASDAQ |
Aug 24, 16:00
173.51
+0.03
(+0.02%)
After-Hours: 20:00
ICON EPS Diluted (Quarterly) : 0.9381 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9381 |
| March 31, 2026 | 1.356 |
| December 31, 2025 | 1.930 |
| September 30, 2025 | -3.673 |
| June 30, 2025 | 2.558 |
| March 31, 2025 | 1.905 |
| December 31, 2024 | 3.584 |
| September 30, 2024 | 2.556 |
| June 30, 2024 | 0.993 |
| March 31, 2024 | 1.782 |
| December 31, 2023 | 2.604 |
| September 30, 2023 | 1.972 |
| June 30, 2023 | 1.399 |
| March 31, 2023 | 1.412 |
| December 31, 2022 | 1.424 |
| September 30, 2022 | 1.941 |
| June 30, 2022 | 1.406 |
| March 31, 2022 | 1.355 |
| December 31, 2021 | 0.9232 |
| September 30, 2021 | -1.167 |
| June 30, 2021 | 1.384 |
| March 31, 2021 | 1.822 |
| December 31, 2020 | 1.900 |
| September 30, 2020 | 1.723 |
| June 30, 2020 | 0.9006 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.701 |
| December 31, 2019 | 1.826 |
| September 30, 2019 | 1.738 |
| June 30, 2019 | 1.687 |
| March 31, 2019 | 1.631 |
| December 31, 2018 | 1.618 |
| September 30, 2018 | 1.540 |
| June 30, 2018 | 1.310 |
| March 31, 2018 | 1.420 |
| December 31, 2017 | 1.30 |
| September 30, 2017 | 1.35 |
| June 30, 2017 | 1.19 |
| March 31, 2017 | 1.29 |
| December 31, 2016 | 1.33 |
| September 30, 2016 | 1.13 |
| June 30, 2016 | 1.08 |
| March 31, 2016 | 1.12 |
| December 31, 2015 | 1.11 |
| September 30, 2015 | 1.02 |
| June 30, 2015 | 0.95 |
| March 31, 2015 | 0.90 |
| December 31, 2014 | 0.73 |
| September 30, 2014 | 0.79 |
| June 30, 2014 | 0.64 |
| March 31, 2014 | 0.57 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.530 |
| Medpace Holdings, Inc. | 4.250 |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | -0.048 |
| Avantor, Inc. | 0.0563 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 72.58M |
| Revenue (Quarterly) | 2.063B |
| Total Expenses (Quarterly) | 1.991B |
| Enterprise Value | 15.98B |
| Gross Profit Margin (Quarterly) | 18.83% |
| Profit Margin (Quarterly) | 3.52% |
| Earnings Yield | 0.32% |
| Operating Earnings Yield | 6.27% |
| Normalized Earnings Yield | 2.987 |